Carrier-Free Gambogic Acid Dimer Self-Assembly Nanomedicines for Rheumatoid Arthritis Treatment

INTRODUCTION: The insufficient targeting delivery of therapeutic agents greatly impeded the treatment outcomes of rheumatoid arthritis (RA). Despite the recognized therapeutic advantages of gambogic acid (GBA) in inflammatory diseases, its high delivery efficiency to inflammatory site still limits i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuling, Nie, Xin, Wu, Yihan, Lin, Longfei, Liao, Qian, Li, Jingjing, Lee, Simon Ming-Yuen, Li, Hui, Zhang, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522496/
https://www.ncbi.nlm.nih.gov/pubmed/37771407
http://dx.doi.org/10.2147/IJN.S422096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522496/
https://www.ncbi.nlm.nih.gov/pubmed/37771407
http://dx.doi.org/10.2147/IJN.S422096

Ejemplares similares